United States v. Comprehensive Drug Testing, Inc.

CourtCourt of Appeals for the Ninth Circuit
DecidedJanuary 23, 2008
Docket05-10067
StatusPublished

This text of United States v. Comprehensive Drug Testing, Inc. (United States v. Comprehensive Drug Testing, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Comprehensive Drug Testing, Inc., (9th Cir. 2008).

Opinion

Volume 1 of 2

FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,  Plaintiff-Appellant, No. 05-10067 v.  D.C. No. COMPREHENSIVE DRUG TESTING, MISC-04-234-SI INC., Defendant-Appellee.  Appeal from the United States District Court for the Northern District of California Susan Illston, District Judge, Presiding

MAJOR LEAGUE BASEBALL PLAYERS  ASSOCIATION, Petitioner-Appellee, No. 05-15006 v.  D.C. No. CV-04-00707-JCM UNITED STATES OF AMERICA, Respondent-Appellant.  Appeal from the United States District Court for the District of Nevada James Mahan, District Judge, Presiding

1077 1078 UNITED STATES v. COMPREHENSIVE DRUG TESTING

IN RE: SEARCH WARRANTS EXECUTED  ON APRIL 8, 2004 AT CDT, INC., No. 05-55354 SEAL 1, D.C. No. Plaintiff-Appellant,  CV-04-02887-FMC v. ORDER AND SUPERSEDING SEAL 2, OPINION Defendant-Appellee.  Appeal from the United States District Court for the Central District of California Florence-Marie Cooper, District Judge, Presiding

Argued and Submitted November 15, 2005—San Francisco, California

Filed January 24, 2008

Before: Diarmuid F. O’Scannlain, Sidney R. Thomas, and Richard C. Tallman, Circuit Judges.

Opinion by Judge O’Scannlain; Partial Concurrence and Partial Dissent by Judge Thomas UNITED STATES v. COMPREHENSIVE DRUG TESTING 1083

COUNSEL

Erika R. Frick, Assistant United States Attorney, San Fran- cisco, California, argued the cause for defendant-appellant, United States of America; United States Attorney Kevin V. Ryan, Appellate Chief Hannah Horsley, Assistant United States Attorney Barbara J. Valliere, San Francisco, California; and Assistant United States Attorneys Matthew A. Parrella, Ross W. Nadel, Jeffrey D. Nedrow, Carter M. Stewart, San Jose, California, were on the briefs.

Elliot R. Peters, Keker & Van Nest, LLP, San Francisco, Cali- fornia, argued the cause for defendants-appellees Comprehen- sive Drug Testing, Inc. and Major League Baseball Players Association; Ethan A. Balogh, Keker & Van Nest, LLP, San Francisco, California, and David P. Bancroft and Jeffrey C. Hallam, Sideman & Bancroft, LLP, San Francisco, California, were on the brief.

ORDER

The petitions for panel rehearing are GRANTED. The opinion and dissent filed on December 27, 2006, are with- drawn. The superseding opinion and dissenting opinion of Judge Thomas will be filed concurrently with this order.

The petition for rehearing en banc is DENIED as moot. Further petitions for rehearing or rehearing en banc may be filed. 1084 UNITED STATES v. COMPREHENSIVE DRUG TESTING OPINION

O’SCANNLAIN, Circuit Judge:

We must decide whether the United States may retain evi- dence it seized from Major League Baseball’s drug testing administrator, and enforce an additional subpoena, as part of an ongoing grand jury investigation into illegal steroid use by professional athletes.

I

These three consolidated cases arise from the federal inves- tigation of the Bay Area Lab Cooperative (“Balco”) and its alleged distribution of illegal steroids to enhance the perfor- mance of professional baseball athletes. The investigation began in August 2002 and, over the following several years, produced evidence—including grand jury testimony— establishing probable cause to believe that at least 10 major league baseball players received illegal steroids from Balco. Today we decide the government’s appeals from the separate adverse orders of three different district courts: (1) an order by Judge Florence-Marie Cooper in the Central District of California, denying reconsideration of her earlier order requir- ing the government to return property seized from Compre- hensive Drug Testing, Inc. in Long Beach, California (“CDT”),1 (2) an order by Judge James Mahan in the District of Nevada, requiring the government to return property seized from Quest Diagnostics, Inc. in Las Vegas, Nevada (“Quest”),2 and (3) an order by Judge Susan Illston in the Northern District of Cali- fornia, quashing the government’s May 6, 2004, subpoenas to CDT and Quest that related to the grand jury sitting in San Francisco, California. 1 The court also required the government to turn over all notes made by agents who reviewed the challenged evidence. 2 Again, the court required the government to give up all notes made by reviewing agents. UNITED STATES v. COMPREHENSIVE DRUG TESTING 1085 A

As part of its investigation into Balco, the government in November 2003 served a grand jury subpoena on Major League Baseball (“MLB”),3 seeking drug testing information for 11 players4 with connections to Balco. One month later, MLB responded that it had no such information.

The government then reasoned that because CDT5 and Quest6 had tested urine samples from MLB players during 2003, those entities—rather than MLB—had to possess the samples and testing records in question. Therefore, the government issued subpoenas both to CDT and to Quest, seeking drug testing information for all MLB players. The subpoenas were returnable on February 5, 2004, but the government extended that date to March 4, 2004, after CDT and Quest promised not to destroy or to alter any of the evidence requested.

Despite protracted negotiations, CDT and Quest resisted producing any of the subpoenaed materials, explaining that they would fight production of even a single drug test all the 3 “Major League Baseball,” an unincorporated association, consists of two professional baseball leagues—the National League of Professional Baseball Clubs and the American League of Professional Baseball Clubs. 4 The names of the players are under seal and are not disclosed in this opinion. 5 CDT is a third-party administrator of “drug and alcohol testing pro- grams” that was hired to oversee MLB’s drug use evaluation program. The company includes “top experts in pharmacology, forensic toxicology, laboratory management, medical review, legal, and administrative compliance.” Comprehensive Drug Testing: About Us, http:// www.cdtsolutions.com/about_us.html (last visited June 13, 2007). 6 Quest offers laboratories that conduct “drugs of abuse testing and ther- apeutic drug monitoring” with “the most advanced methodologies avail- able.” Quest Diagnostics: Diagnostic Testing & Services, http:// www.questdiagnostics.com/brand/business/b_bus_lab_index.html (last visited June 13, 2007). Quest’s laboratory in Las Vegas performed the drug testing on the player specimens at issue in these consolidated appeals. 1086 UNITED STATES v. COMPREHENSIVE DRUG TESTING way to the Supreme Court. Following further negotiations, the government, believing that a narrower subpoena might be effective, issued new subpoenas on March 3, 2004, seeking documents related only to eleven7 players with Balco connec- tions. These new subpoenas were returnable on April 8, 2004.

Two days before the new return date, the Major League Baseball Players’ Association—the union representing ath- letes who play for Major League Baseball8 —informed the government that it intended to file a motion to quash the sub- poenas. The following day, as promised, CDT and the Players Association filed such a motion in the Northern District of California before United States District Judge Jeffrey White.

B

After learning of the planned motion to quash, the govern- ment applied on April 7, 2004, for warrants to search CDT’s Long Beach office and Quest’s Las Vegas laboratory. The government expected to find testing evidence at both loca- tions and knew that the information at CDT would be needed to obtain all relevant records from Quest, because Quest stored each testing record by code, not name, and CDT pos- sessed the information identifying the code(s) that corre- sponded to each player in its testing program.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Silverthorne Lumber Co. v. United States
251 U.S. 385 (Supreme Court, 1920)
United States v. Robinson
361 U.S. 220 (Supreme Court, 1960)
Wong Sun v. United States
371 U.S. 471 (Supreme Court, 1963)
Katz v. United States
389 U.S. 347 (Supreme Court, 1967)
Warth v. Seldin
422 U.S. 490 (Supreme Court, 1975)
Whalen v. Roe
429 U.S. 589 (Supreme Court, 1977)
Nixon v. Warner Communications, Inc.
435 U.S. 589 (Supreme Court, 1978)
Rakas v. Illinois
439 U.S. 128 (Supreme Court, 1979)
Payton v. New York
445 U.S. 573 (Supreme Court, 1980)
Texas v. Brown
460 U.S. 730 (Supreme Court, 1983)
Maryland v. Garrison
480 U.S. 79 (Supreme Court, 1987)
Arizona v. Hicks
480 U.S. 321 (Supreme Court, 1987)
United States v. Owens
484 U.S. 554 (Supreme Court, 1988)
Pennell v. City of San Jose
485 U.S. 1 (Supreme Court, 1988)
Huddleston v. United States
485 U.S. 681 (Supreme Court, 1988)
Skinner v. Railway Labor Executives' Assn.
489 U.S. 602 (Supreme Court, 1989)
Horton v. California
496 U.S. 128 (Supreme Court, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Comprehensive Drug Testing, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-comprehensive-drug-testing-inc-ca9-2008.